Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
N-(5-Chloropyridin-2-yl)-2-(4-cyanobenzamido)-5-methoxybenzamide serves as a versatile drug intermediate utilized in the synthesis of active pharmaceutical compounds. Its unique chemical structure enables the production of various biologically active molecules, making it valuable in medicinal chemistry research. This compound is essential for developing new therapeutic agents aimed at a range of diseases. -
Drug Impurity
Afatinib impurity 3 is a quantified impurity of Afatinib, a selective irreversible inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. This compound is primarily utilized in the evaluation of drug purity and quality control in pharmaceutical research and development. Its characterization is essential for compliance with regulatory standards and for ensuring the safety and efficacy of Afatinib-based therapies. -
Drug Impurity
Apixaban impurity 11 is a known impurity associated with the anticoagulant Apixaban. This compound is essential for the characterization of Apixaban in pharmaceutical formulations and stability studies. Its presence and quantification are important in ensuring the quality and efficacy of the drug during development and production processes. -
Drug Impurity
Ropinirole impurity 12 is a chemical impurity associated with the analgesic and anti-Parkinson agent, Ropinirole. This compound plays a critical role in the assessment of drug purity and stability, as it can potentially affect the pharmacological profile of the parent compound. Additionally, Ropinirole impurity 12 is useful in research focused on formulation development, quality control, and compliance with regulatory standards for pharmaceutical products. -
Drug Impurity
Indobufen Impurity 6 is a structural impurity associated with Indobufen. It serves as a valuable reference standard for analytical and quality control applications in pharmaceutical research. The characterization of this impurity can aid in assessing the purity and stability of Indobufen formulations, contributing to the understanding of its pharmacological properties. -
Drug Intermediate
Tofacitinib Impurity T is a synthetic intermediate primarily used in the production of bioactive compounds. This compound consists of a propanamide moiety linked to a piperidinyl group and is relevant for research focused on the synthesis of therapeutic agents. Its role as a building block in organic chemistry facilitates the development of novel pharmaceuticals targeting various diseases. -
Drug Impurity
Terbinafine impurity 1 hydrochloride is a known impurity of the antifungal agent terbinafine hydrochloride. This compound is important for analytical studies focused on drug purity, stability, and formulation development. Researchers can use it to validate analytical methods and ensure compliance with regulatory standards in pharmaceutical testing. -
Drug Impurity
Metoprolol impurity 10 is a characterized impurity of the beta-blocker Metoprolol, primarily affecting the drug's purity assessment and quality control. Its analysis is essential in pharmaceutical research to ensure compliance with regulatory standards. This compound serves as a reference for detecting and quantifying impurities in formulation studies and stability assessments of Metoprolol. -
Drug Impurity
Dronedarone impurity 25 hydrochloride is a designated impurity associated with the antiarrhythmic drug Dronedarone. It serves as a crucial reference standard in the analysis and quality control of Dronedarone, facilitating the evaluation of drug purity and stability. This compound is significant for researchers and pharmaceutical developers engaged in the synthesis, development, and regulatory assessment of cardiovascular therapeutics. -
Drug Intermediate
Benzeneethanamine, 2-bromo-α,α-dimethyl serves as a crucial drug intermediate, facilitating the synthesis of diverse active pharmaceutical compounds. This compound exhibits significant potential in medicinal chemistry, particularly in the development of novel therapeutic agents. Its unique structural properties make it a valuable building block in pharmaceutical research and development. -
Drug Impurity
Sitagliptin impurity 29 is a known impurity of the DPP-4 inhibitor Sitagliptin. Its identification and characterization are crucial for assessing the purity of Sitagliptin during drug development and quality control processes. This compound is important for researchers investigating the safety, efficacy, and regulatory compliance of Sitagliptin formulations. -
Drug Intermediate
1,2,3-Trimethoxybenzene serves as a drug intermediate, particularly in the synthesis of 2,6-dimethoxy-1,4-benzoquinone. As a derivative of lignin, it is of interest in studies involving natural compounds and serves as a potential biomarker for certain dietary sources, notably in tea. Its chemical properties and biological relevance make it valuable for research applications in pharmacology and food sciences. -
Drug Impurity
Posaconazole impurity 4 is a characterized impurity of the antifungal agent Posaconazole. It serves as a reference standard for analytical studies and quality control processes in pharmaceutical research. The identification and quantification of this impurity are essential for ensuring the purity and efficacy of Posaconazole formulations in clinical settings. -
Drug Impurity
Sofosbuvir impurity 3 is a characterized impurity of the antiviral agent Sofosbuvir, primarily targeting hepatitis C virus replication. This compound serves as a vital reference standard in the analytical evaluation of Sofosbuvir formulations, ensuring the quality and safety of therapeutic applications. Its assessment is crucial for researchers conducting studies on drug metabolism, stability, and impurity profiling in pharmaceutical development. -
Drug Intermediate
5,6,7,8-Tetrahydro-2-quinolone is a synthetic intermediate utilized in pharmaceutical synthesis. This compound serves as a critical building block in the development of various therapeutic agents. Its chemical structure facilitates the formation of biologically active derivatives, making it a valuable reagent for drug discovery and development. -
Drug Intermediate
2-Nitrobenzamide is a versatile drug intermediate known for its role in the synthesis of various active pharmaceutical compounds. It serves as a key building block in organic synthesis, facilitating the development of biologically active substances. This compound is particularly valuable in medicinal chemistry and pharmaceutical research, supporting the exploration of novel therapeutics. -
Drug Impurity
Brimonidine impurity 7, also known as 6-Quinoxalinamine, is a chemical impurity associated with the synthesis of Brimonidine. This compound serves as an important reference standard in analytical chemistry for the detection and quantification of impurities in pharmaceutical formulations. Its characterization can aid in understanding the stability and quality of Brimonidine-related products. -
Drug Impurity
Sacubitrilat impurity 34 is a known impurity associated with Sacubitrilat, a vasodilator that inhibits neprilysin, thereby increasing levels of natriuretic peptides. This compound is primarily utilized in drug development and quality control assessments to ensure the purity of Sacubitrilat formulations. Its presence in analytical studies aids in understanding the metabolism and safety profiles of the parent drug. -
Drug Impurity
Dapagliflozin impurity 111 is an impurity associated with the antidiabetic agent Dapagliflozin, which targets sodium-glucose cotransporter 2 (SGLT2). This compound serves as a critical analytical reference for the assessment of drug purity and quality control in pharmaceutical formulations. The study of this impurity is important for understanding the stability and safety profiles of SGLT2 inhibitors in drug development. -
Drug Impurity
Vitamin Impurity 3 is a recognized impurity associated with Vitamin compounds. It may arise during synthesis or degradation processes and is primarily investigated for its potential effects on the stability and efficacy of vitamin formulations. This reagent is essential for quality control and regulatory compliance in pharmaceutical research, allowing scientists to assess the purity of vitamin products and their implications for safety and effectiveness. -
Drug Intermediate
5-(M-Tolyl)tetrazole serves as a crucial intermediate in the synthesis of diverse bioactive compounds. This tetrazole derivative is employed in medicinal chemistry for the development of pharmaceuticals, offering a versatile building block for various therapeutic agents. Its unique structure allows for the potential modification and enhancement of biological activity in target compounds, making it an essential reagent for chemical research and drug development. -
Drug intermediate
2-Amino-4-phenylthiazole is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a precursor for synthesizing suberoylanilide hydroxamic acid (SAHA) analogs, which exhibit inhibitory effects on cancer cell growth. Additionally, it is instrumental in the development of ketone histone deacetylase inhibitors, demonstrating antitumor activity in vivo. -
Drug Intermediate
tert-Butyl 4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazine-1-carboxylate serves as an important drug intermediate, facilitating the synthesis of various bioactive compounds. This reagent is valuable in research aimed at developing new pharmaceuticals, particularly in the fields of medicinal chemistry and drug discovery. Its structural characteristics enable the formation of complex molecules, making it a crucial component in the production of therapeutic agents. -
Drug Impurity
4-Chloro-2-methoxybenzonitrile is identified as a drug impurity primarily involved in pharmaceutical applications. Its presence may affect the safety and efficacy of drug formulations, making it a critical compound for analytical chemistry studies. Researchers utilize this reagent to investigate the impact of impurities in drug development and quality control processes. -
Drug Intermediate
4-Methylquinaldine is a quinoline derivative primarily utilized as a drug intermediate in chemical synthesis. This compound exhibits significant potential in the development of various pharmaceuticals, contributing to the creation of biologically active molecules. Its structural properties make it valuable for research applications in medicinal chemistry and drug formulation. -
Drug Intermediate
Trimethoxy(4-phenylbutyl)silane serves as a versatile drug intermediate, facilitating the synthesis of various active pharmaceutical ingredients. Its silane structure allows for effective incorporation into complex molecular frameworks, aiding in the development of therapeutically relevant compounds. This reagent is suitable for applications in medicinal chemistry and chemical biology, contributing to advancements in drug discovery and development. -
Drug Impurity
Ilurodoline impurity 10 is a synthetic impurity associated with the drug Ilurodoline. This compound serves as a valuable reference standard for analytical and quality control applications in the pharmaceutical industry. Its characterization is crucial for ensuring the purity and safety of Ilurodoline in drug formulation and development processes. -
Drug Impurity
Tadalafil impurity 16 is a known impurity of Tadalafil, primarily involved in the assessment of pharmaceutical quality and characterization of drug substances. This compound serves as a critical reference standard for the analysis of Tadalafil formulations, ensuring compliance with regulatory guidelines. Its presence can impact the efficacy and safety profiles of Tadalafil, making it essential for analytical and quality control applications in drug development and manufacturing. -
Drug Impurity
Arolol impurity 2 is a characterized drug impurity associated with Arolol. Due to its presence, it is essential for the assessment of pharmaceutical formulations and quality control processes. This compound is used in research to ensure the purity and safety of drug products, ultimately aiding in the development of therapeutically effective formulations. -
Drug Impurity
Rosuvastatin impurity 52 is a known impurity of the cholesterol-lowering agent Rosuvastatin, primarily affecting its purity profile. This compound is crucial for quality control and analytical studies, aiding in the assessment of synthetic processes and regulatory compliance. It is utilized in pharmaceutical research to ensure the integrity of drug formulations and to evaluate the safety and efficacy of Rosuvastatin. -
Drug Impurity
BOC-Ile-N(OCH3)CH3 is a chemical compound that serves as a drug impurity, specifically an N-derivative of isoleucine. This reagent is pivotal in pharmaceutical development and quality control, as it allows for the analysis of drug formulations and the understanding of synthesis pathways. Its relevance in research extends to evaluating the stability and purity of drug substances. -
Drug Impurity
Uradil Impurity 1 is identified as an impurity of Uradil, primarily serving as a reference standard in drug development and quality control. Its presence may affect the safety and efficacy profiles of pharmaceutical formulations, making it critical for analytical characterization. Research applications include stability testing and impurity profiling to ensure compliance with regulatory standards in drug formulation. -
Drug Intermediate
1-(Piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one Hydrochloride serves as a crucial intermediate in the synthesis of diverse bioactive compounds. This reagent is instrumental in the development of pharmaceutical agents, facilitating the exploration of novel therapeutic pathways. Its structure allows for further chemical modifications, expanding its utility in drug discovery and chemical biology research. -
Drug Intermediate
N,N-Dimethyl-2-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]acetamide serves as a key drug intermediate in the synthesis of diverse biologically active compounds. This compound facilitates the development of novel pharmaceuticals through its role in organic synthesis reactions. Its structural properties make it suitable for various research applications in medicinal chemistry and drug discovery. -
Drug Impurity
2-Cyanoethyl acetoacetate is a chemical compound that serves as a drug impurity. It is significant in analytical chemistry for assessing the purity of pharmaceutical formulations and studying degradation pathways of drug candidates. Researchers utilize this reagent to investigate the stability and quality control of various therapeutic agents. -
Drug Intermediate
Methyl 3-methoxy-4-nitrobenzoate is a versatile drug intermediate that serves as a crucial building block in the synthesis of various biologically active compounds. Its unique structure supports the development of new pharmaceuticals by facilitating modifications that enhance efficacy and selectivity. This compound is particularly relevant in medicinal chemistry and organic synthesis applications, where it is utilized to create target molecules with specific therapeutic properties. -
Drug Impurity
Nintedanib impurity 3 is a chemical impurity related to Nintedanib, a receptor tyrosine kinase inhibitor. This compound is significant for analytical and quality control purposes in pharmaceutical research and development. Its identification and quantification are crucial for ensuring the safety and efficacy of Nintedanib formulations. -
Drug Intermediate
3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde is a versatile drug intermediate utilized in the synthesis of various bioactive compounds. This compound serves as a crucial building block in medicinal chemistry, facilitating the development of pharmaceuticals with targeted biological activities. Its utility in organic synthesis makes it an important reagent for researchers in the field of drug discovery and development. -
Drug Intermediate
3-Thiophenecarboxaldehyde is a thiophene derivative that serves as a substrate for biocatalytic reduction to 3-thiophenemethanol, facilitated by Pseudomonas putida S12 cells. This compound functions as an important intermediate in synthetic pathways. However, it exhibits toxicity toward Pseudomonas putida S12 at elevated concentrations, negatively impacting specific growth rates and final biomass yields. Its unique properties make it useful for research in biocatalysis and metabolic engineering. -
Drug Impurity
7-Deazapurine impurity 1 is a known impurity associated with the synthesis of purine derivatives. This compound may arise during the production of specific pharmaceuticals and is critical for assessing the purity and quality of drug formulations. Its analysis is essential in pharmaceutical research and development to ensure compliance with regulatory standards. -
Drug Impurity
Linagliptin impurity 34 is a chemical impurity associated with Linagliptin, a DPP-4 inhibitor. This substance is critical for the assessment of drug purity and quality control in pharmaceutical research. Its characterization and analytical evaluation are essential for understanding the metabolic profile and potential safety implications of Linagliptin formulations. -
Drug Impurity
Tofacitinib impurity 32 is a chemical impurity associated with the kinase inhibitor Tofacitinib. Its characterization is essential for assessing the purity and quality of pharmaceutical formulations. This reagent is utilized in research focused on the development and validation of analytical methods for drug analysis, as well as for stability studies in pharmaceutical sciences. -
Drug Intermediate
(2S,5S)-Methyl 5-phenylpyrrolidine-2-carboxylate hydrochloride serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its structural properties facilitate the formation of biologically active molecules, making it valuable in medicinal chemistry research. This reagent is particularly useful in the development of novel therapeutics targeting various diseases. -
Drug Impurity
Timolol impurity 1 is a known impurity of the beta-adrenergic antagonist Timolol. Its characterization is essential for quality control in pharmaceutical development, ensuring the purity and safety of the final drug product. This reagent is useful for analytical studies and method validation in drug formulation and stability testing. -
Drug Intermediate
3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile serves as a crucial drug intermediate in the synthesis of diverse bioactive molecules. This compound's structural features facilitate its utilization in medicinal chemistry for developing pharmaceuticals targeting various biological pathways. Its application in the research and synthesis of novel therapeutic agents underscores its significance in drug discovery efforts. -
Drug Intermediate
2'-Hydroxy-3,4-dimethoxydihydrochalcone serves as a drug intermediate in the synthesis of diverse bioactive compounds. This structural derivative of dihydrochalcone facilitates the production of various pharmaceuticals and agrochemicals by providing versatile chemical functionality. Its application in medicinal chemistry supports the development of novel therapeutic agents. -
Drug Impurity
Suvorexant impurity 1 is a by-product of Suvorexant synthesis, primarily associated with drug formulation and quality control. This impurity may be utilized in analytical studies to examine the effects of impurities on potency and efficacy in drug development. Research applications include stability testing and profiling of Suvorexant formulations, contributing to better understanding of safety and pharmacokinetics in preclinical studies. -
5-ASA Impurity
3-Aminosalicylic acid is a key impurity associated with the synthesis of 5-Aminosalicylic acid, a known agonist of PPARγ and an inhibitor of p21-activated kinase 1 (PAK1) and NF-κB. This compound is primarily used in research related to inflammatory bowel diseases such as Crohn's disease and ulcerative proctitis. Its role in modulating these pathways makes it significant for studies focused on therapeutic interventions and drug development in gastrointestinal conditions. -
Drug Impurity
Nintedanib impurity 7 is a known impurity associated with Nintedanib, targeting multiple receptor kinase pathways. It serves as a critical reference standard for assessing the purity of Nintedanib formulations in pharmacokinetic studies and quality control. This compound is valuable for researchers examining drug safety, efficacy, and metabolic pathways related to Nintedanib and its therapeutic applications. -
Drug Intermediate
2-Amino-6-fluoro-4-(2-methoxyethoxy)benzonitrile functions as a crucial intermediate in drug synthesis. Its unique structure facilitates the development of a range of biologically active compounds. This reagent is utilized in medicinal chemistry and pharmaceutical research for generating novel therapeutic agents.
